Summit Therapeutics shares owned by CIBC Global Asset Management
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by CIBC Global Asset Management
from 13F filings
Historical chart of CIBC Global Asset Management investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by CIBC Global Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by CIBC Global Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $457k | 22k | 20.66 |
| 2025-06-30 | $471k | 22k | 21.28 |
| 2025-03-31 | $427k | 22k | 19.29 |
| 2024-12-31 | $385k | 22k | 17.85 |
| 2024-09-30 | $448k | 20k | 21.90 |
| 2024-06-30 | $154k | 20k | 7.80 |
More positions owned by CIBC Global Asset Management
View all positions for CIBC Global Asset Management